Viewing Study NCT03454451


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2025-12-25 @ 9:35 PM
Study NCT ID: NCT03454451
Status: COMPLETED
Last Update Posted: 2023-12-21
First Post: 2018-02-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Sponsor: Corvus Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module